Uses of antibodies against AChE and peptides thereof

Details Uses of antibodies against AChE and peptides thereof Uses of antibodies against AChE and peptides thereof

2006-06-20

2006-06-20

Andres, Janet L. (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C530S387100, C530S300000

Reexamination Certificate

active

07063948

ABSTRACT:
The invention relates to antibodies recognizing acetylcholinesterase or a C-terminal peptide derived from acetyl-cholinesterase, useful in diagnosing central nervous system (CNS) stress, elevated glucocorticoid level, disruption of the blood-brain barrier or Alzheimer's disease. The invention also relates to methods for the diagnosis of central nervous system (CNS) stress, elevated glucocorticoid level or disruption of the blood-brain barrier in a mammal, by use of the antibodies of the invention.

REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 5840479 (1998-11-01), Little et al.
patent: 173494 (1986-03-01), None
patent: 184187 (1986-06-01), None
patent: 171496 (1991-05-01), None
patent: 125023 (1991-06-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 87/02671 (1987-05-01), None
patent: WO 98/22132 (1998-05-01), None
patent: WO 99/15695 (1999-04-01), None
Boschetti, et al, 1996, Clinical Chem., 42(1): 19-23.
Karpel, et al, 1994, Accession No. S71129.
Li, et al, 1991, J. Biol. Chem, 266(34): 23083-23090.
Loft, A., 1995, Danish Medical Bulletin, 42(1):54-70.
Sternfeld, Shoham, et al, 2000, PNAS, 97(15): 8647-8652.
Kaufer, D. and Soreq, H., 1999, Curr. Opin. Neurol., 12(6): (abstract).
Nijholt, et al, 2004, Mol. Psychiatry, 9: 174-183.
Magariños, et al, 1997, Proc. Natl. Acad. Sci., 94: 14002-14008.
Ausubel, FM., Brent, R., Kingston, RE., Moore, DD., Seidman, JG., Smith, JA., Struhl, K. Current Protocols In Molecular Biology, vol. I. and II, Greene Publishing Associates and Wiley-Interscience, 1988.
Azziz-Aloya, RB., Seidman, S., Timberg, R., Sternfeld, M., Zakut, H. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions ofXenopusembryos, Proc. Natl. Acad. Sci. USA, vol. 90, pp.2471-2475, Mar. 1993.
Boschetti, N, Brodbeck, U., Jensen, SP., Koch, C., Norgaard-Pedersen, B. Monoclonal antibodies against a C-terminal peptide of human brain acetylcholinesterase distinguish between erythrocyte and brain acetylcholinesterases, Clinical Chemistry 42:1, 19-23, 1996.
Boulianne, GL., Hozumi, N., Shulman, MJ. Production of functional chimaeric mouse/human antibody, Nature vol. 312, Dec. 13, 1984.
Cabilly, S., Riggs, AD., Pande, H., Shively, JE., Holmes, WE., Rey, M., Perry, J., Wetzel, R., Heyneker, HL. Generation of antibody activity from immunoglobulin polypeptide chains produced inEscherichia coli, Proc. Natl. Acad. Sci. USA, vol. 81, pp. 3273-3277, Jun. 1984.
Grisaru, T, Lev-Lehman, E., Shapira, M., Chaikin, E., Lessing, JB., Eldor, A., Eckstein, F., Soreq. H. Human Osteogenesis Involves Differentiation-Dependent Increases in the Morphogenically Active 3' Alternative Splicing Variant of Acetylcholinesterase, Molecular and Cellular Biology, Jan. 1999, P. 788-795.
Guan, K., Dixon, JE. Eukaryotic Proteins Expressed inEscherichia coli: An Improved Thrombin Cleavage and Purification Procedure of Fusion Proteins with Glutathione S-Transferase, Analytical Biochemistry 192, 262-267, 1991.
Harlow,E., Lane, D. Antibodies, A Laboratory Manual, Cold Springs Harbor Laboratory, 1988.
Kaufer, D., Friedman, A., Seidman, S., Soreq, H. Acute stress facilities long-lasting changes in cholinergic gene expression, Nature, vol. 393, May 28, 1998.
Köhler, G., Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol. 256, Aug. 7, 1975.
Loft, AG. Immunochemical determination of amniotic fluid acteycholinesterase in the antenatal diagnosis of open neutral tube defects, Danish Medical Bulletin, 42(1), 54-70, Ref: 138, Feb. 1995.
Mäder, M., Soerensen, K., Wiedman, Th., Dickman, Felgenhauer, K. Neuronal Acetycholinesterase Levels in Cerebrospinal Fluid and Serum Determined by a Specific and Sensitive Immunoassay, European Journal of Clinical Chemistry and Clinical biochemistry, 29(1) 51-55, Jan. 1991.
Morrison, SL., Johnson, MJ., Herzenberg, LA., Or VT. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. USA, vol. 81, pp. 6851-6855, Nov. 1984.
Novales-Li, P., Lane, T. Isolation of Human Acetylcholinesterase from Post-Mortem Bain Tissue Samples of Alzheimer's Disease Patients and the Production of Monoclonal Antibodies, Philippine Journal of Science, vol. 124(1), 39-51, 1995.
Sambrook, J., Fritsch, EF., Maniatis, T. Molecular Cloning, A Laboratory Manual 2ndEdition, Cold Sprongs Harbor Laboratory, 1989.
Seidman, S., Sternfeld, M., Aziz-Aloys, BR., Timberg, R., Kaufer-Nachum, D., Soreq, H. Synaptic and Epidermal Accumulations of Human Acetylcholinesterase Are Encoded by Alternative 3′-Terminal Exons, Molecular and Cellular Biology, 2993-3002, Jun. 1995.
Sternfeld, M., Patrick, JD., Soreq, H. Position effect variegations and brain-specific silencing in transgenic mice over expressing human actylcholinesterase variants, J. Physiol., Paris, 92, 249-55, 1998.
Wahl, RL., Parker, CW., Philpott, GW. Investigative Nuclear Medicine, 24, 316-325, 1983.

Affiliated with

Also associated with

Rating

Uses of antibodies against AChE and peptides thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of antibodies against AChE and peptides thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of antibodies against AChE and peptides thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3708370